Stockscreener 앱 받기
30.75
2.77%
0.83
전일 마감가:
$29.92
열려 있는:
$29.85
하루 거래량:
159.29K
Relative Volume:
0.85
시가총액:
$601.14M
수익:
-
순이익/손실:
$-83.49M
주가수익비율:
-6.8993
EPS:
-4.457
순현금흐름:
$-60.29M
1주 성능:
-13.67%
1개월 성능:
+5.42%
6개월 성능:
+12.19%
1년 성능:
+78.05%
1일 변동 폭
$29.73
$31.12
1주일 범위
$28.96
$35.67
52주 변동 폭
$14.38
$39.53
Tectonic Therapeutic Inc Stock (TECX) Company Profile
명칭
Tectonic Therapeutic Inc
전화
(339) 666-3320
주소
490 ARSENAL WAY, WATERTOWN
Compare TECX vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
30.75 | 704.75M | 0 | -83.49M | -60.29M | -4.457 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-05-26 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2026-04-14 | 개시 | Stifel | Buy |
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-09-03 | 개시 | Oppenheimer | Outperform |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-06-11 | 재개 | Raymond James | Outperform |
| 2025-04-21 | 개시 | Mizuho | Outperform |
| 2024-11-20 | 개시 | Raymond James | Outperform |
| 2024-08-22 | 개시 | Wells Fargo | Overweight |
| 2024-06-26 | 개시 | Piper Sandler | Overweight |
| 2024-06-24 | 개시 | TD Cowen | Buy |
| 2023-12-18 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-05 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-05-27 | 개시 | Needham | Buy |
| 2021-03-09 | 개시 | Barclays | Overweight |
| 2021-03-02 | 개시 | Stifel | Hold |
| 2020-11-11 | 개시 | Berenberg | Buy |
| 2020-03-31 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | 개시 | Mizuho | Buy |
| 2019-04-05 | 개시 | Janney | Buy |
| 2018-10-10 | 개시 | Guggenheim | Buy |
| 2018-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-17 | 개시 | H.C. Wainwright | Buy |
| 2018-07-16 | 개시 | Wedbush | Outperform |
| 2018-07-16 | 개시 | Wells Fargo | Outperform |
모두보기
Tectonic Therapeutic Inc 주식(TECX)의 최신 뉴스
Tectonic Therapeutic (NASDAQ: TECX) ex-director to sell 10,200 shares - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Upgraded to "Hold" at Zacks Research - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Trading 5.6% HigherShould You Buy? - MarketBeat
Tectonic Therapeutic CSO McNamara sells $1,505 in shares - Investing.com
Tectonic Therapeutic CSO McNamara sells $1,505 in shares By Investing.com - Investing.com India
TECX (TECX) insider plans 129-share sale and notes prior 10b5-1 trade - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 13.3%Here's What Happened - MarketBeat
Truist Financial Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $60 - Moomoo
Wells Fargo Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Cuts Target Price to $93 - Moomoo
Tectonic Therapeutic (NASDAQ:TECX) Upgraded by Wall Street Zen to "Sell" Rating - MarketBeat
Tectonic Therapeutic Inc (TECX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tectonic Therapeutic (NASDAQ:TECX) Announces Earnings Results, Beats Estimates By $0.17 EPS - MarketBeat
TECX Maintained by Wells Fargo -- Price Target Lowered to $93.00 - GuruFocus
Piper Sandler Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $76 - Moomoo
Wells Fargo & Company Issues Pessimistic Forecast for Tectonic Therapeutic (NASDAQ:TECX) Stock Price - MarketBeat
Tectonic Therapeutic, Inc. (TECX) Investor Outlook: Exploring A 159.58% Potential Upside - DirectorsTalk Interviews
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
TECX Q1 2026 Earnings: Wider-than-Expected Loss as Clinical-Stage Pipeline Remains the FocusEarnings Revision Report - vinanet.vn
Tectonic Therapeutic, Inc. Stock 12‑Month Price Target Cut to $77.56, Implies 157% Upside - TradingView
Tectonic Therapeutic Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Tectonic Therapeutic, Inc. 2Q 2026: Net loss $22.3M, EPS $(1.18) — 10-Q Summary - TradingView
TECX: TX45 Phase 2 trial enrollment completed; topline results expected Q1 2027 - TradingView
Tectonic Therapeutic reports Q2 net loss $22.3M, cash $227.1M; TX45 enrollment complete - TradingView
Press Release: Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights - Moomoo
TECX,RNAC Options - Finviz
Tectonic Therapeutic Inc expected to post a loss of $1.35 a shareEarnings Preview - TradingView
Tectonic Therapeutic (TECX) Holds Ground at $27.95 as Traders Eye $26.55 SupportTurnaround Stocks - vinanet.vn
Tectonic Therapeutic (TECX) Expected to Announce Earnings on Thursday - MarketBeat
Tectonic Therapeutic Inc (TECX) Valuation: PE, PB & Fair Value Analysis - TradingKey
TECX|Tectonic Therapeutic Inc|Price:30.370|Chg%:-1.240 - TradingKey
Tectonic Therapeutic Inc (TECX) Cash Flow - TradingKey
TECX|Tectonic Therapeutic Inc|Price:30.590|Chg%:+0.220 - TradingKey
First Light Asset Management LLC Takes $20.02 Million Position in Tectonic Therapeutic, Inc. $TECX - MarketBeat
Tectonic Therapeutic Inc (TECX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Tectonic Therapeutic Inc (TECX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tectonic Therapeutic Inc (TECX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tectonic Therapeutic, Inc. Revenue Breakdown – NASDAQ:TECX - TradingView
Tectonic Therapeutic Inc (TECX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Tectonic Therapeutic Inc (TECX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Tectonic Therapeutic Inc (TECX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price to book forward of Tectonic Therapeutic, Inc. – NASDAQ:TECX - TradingView
Tectonic Therapeutic (TECX) Slips 3.9% as Shares Test Key Support LevelsPoint of Control - vinanet.vn
Tectonic Therapeutic, Inc. (NASDAQ: TECX) Share Price, TECX Stock News, TECX Share Price & Updates - Kalkine
TECX Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues Pipeline Advancement - vinanet.vn
Tectonic Therapeutic (NASDAQ:TECX) Stock Rating Lowered by Zacks Research - MarketBeat
TECX Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue PhaseConsensus Miss Rate - vinanet.vn
TECX Q1 2026 Earnings: EPS Miss as Clinical-Stage Biotech Advances PipelineShare Repurchase Impact - vinanet.vn
TECX Q1 2026 Earnings: EPS Miss Widens as Pre-Revenue Biotech Reports Negative SurpriseRevenue Miss Report - vinanet.vn
TECX Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues R&D InvestmentNet Income Trends - dars.gov.et
Enterprise value to revenue forward of Tectonic Therapeutic, Inc. – BOATS:TECX - TradingView
Tectonic Therapeutic Inc (TECX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tectonic Therapeutic Inc 주식 (TECX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| McNamara Peter | Chief Scientific Officer |
Aug 25 '26 |
Option Exercise |
14.71 |
43 |
633 |
55,328 |
| McNamara Peter | Chief Scientific Officer |
Aug 25 '26 |
Sale |
36.52 |
43 |
1,570 |
55,285 |
0.86%
0.31%
자본화:
|
볼륨(24시간):